13 January 2025 Lilly to Acquire Scorpion Therapeutics’ Mutant-Selective PI3Kα Inhibitor Program read more
8 January 2025 LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia read more
1 October 2024 Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer read more
26 September 2024 ReCode Therapeutics Doses First Patient in Phase 1b Clinical Study of RCT2100 for the Treatment of Cystic Fibrosis read more
